Halozyme Therapeutics, Inc. (HALO)
67.70
-1.25
(-1.81%)
USD |
NASDAQ |
Dec 30, 16:00
67.51
-0.19
(-0.28%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 49.46% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.47% |
| Merck & Co., Inc. | 33.68% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Bristol Myers Squibb Co. | 17.96% |
| Protalix Biotherapeutics, Inc. | 13.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 139.4% |
| Return on Assets | 27.69% |
| Return on Invested Capital | 30.68% |
| Gross Profit Margin (Quarterly) | 79.39% |
| Operating Margin (Quarterly) | 61.51% |
| Return on Net Operating Assets | 43.64% |